Your browser doesn't support javascript.
loading
Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage.
Angeletti, Davide; Yewdell, Jonathan W.
Afiliação
  • Angeletti D; Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Yewdell JW; Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: jyewdell@nih.gov.
Trends Immunol ; 39(7): 549-561, 2018 07.
Article em En | MEDLINE | ID: mdl-29789196
ABSTRACT
Adaptive immune responses against antigenically variable viruses and cellular pathogens are efficient in many cases, but largely limited to the infecting or immunizing strain. A major factor that limits immunity is immunodominance (ID), the hierarchical focusing of adaptive immune responses on a subset of antigenic determinants. While CD8+ T cell ID has been extensively studied, studies of basic mechanisms of B cell ID are limited, despite the importance of antibodies (Abs) for durable protection against pathogens. Here, we review recent progress in understanding the basic rules and mechanisms of B cell ID, compare B and CD8+ T cell ID, and outline challenges to overcoming ID to develop Ab-based 'universal' vaccines for influenza A and other highly variable viruses.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Linfócitos B / Linfócitos T CD8-Positivos / Imunidade Adaptativa / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Linfócitos B / Linfócitos T CD8-Positivos / Imunidade Adaptativa / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article